Loading...

Brilliant Violet 421™ anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IHC_M1-70_BV421_071012
BL/6 mouse lymph nodes, fixed O/N in PLP, blocked with 10% rat serum, stained with CD11b-BV421™ (red), B220-Alexa Fluor® 647 (blue), CD14-FITC (green) in 1% BSA and 0.1% Tween-20 in PBS. Images were acquired with an automated widefield microscope (Nikon Eclipse Ti) and a CCD camera (QImaging Retiga 2000R). Emitted light was collected through 440/40, 525/50, and 700/75 nm bandpass filters. Images provided by Ann Haberman and Christine Podolski, Yale University.
  • IHC_M1-70_BV421_071012
    BL/6 mouse lymph nodes, fixed O/N in PLP, blocked with 10% rat serum, stained with CD11b-BV421™ (red), B220-Alexa Fluor® 647 (blue), CD14-FITC (green) in 1% BSA and 0.1% Tween-20 in PBS. Images were acquired with an automated widefield microscope (Nikon Eclipse Ti) and a CCD camera (QImaging Retiga 2000R). Emitted light was collected through 440/40, 525/50, and 700/75 nm bandpass filters. Images provided by Ann Haberman and Christine Podolski, Yale University.
  • M1slash70_BV421_032911
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) Brilliant Violet 421™ (filled histogram) or rat IgG2b, κ Brilliant Violet 421™ isotype control (open histogram). Data shown was gated on myeloid cell population.
Compare all formats See Brilliant Violet 421™ spectral data
Cat # Size Price Save
101235 125 µL ¥36,300
101251 50 µg ¥51,730
101236 500 µL ¥68,530
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µL volume. For flow cytometric staining using the µL sizes, the suggested use of this reagent is 5 µL per million cells in 100 µL staining volume or 5 µL per 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  2. Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed
  3. Chai Y, et al. 2016. PLoS One. 11: 0162853. PubMed
  4. Moderzynski K, et al. 2016. PLoS Negl Trop Dis. . PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Liu J, et al. 2019. Immunity. 50:600. PubMed
  7. Ilinykh PA, et al. 2020. Cell Host & Microbe. 27(6):976-991. PubMed
  8. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  9. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  10. He D, et al. 2022. Immunity. 55:159. PubMed
  11. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  12. Jeong GU, et al. 2022. Microbiol Spectr. 10:e0109122. PubMed
  13. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  14. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  15. Chithanathan K, et al. 2022. Cells. 11: . PubMed
  16. Tu J, et al. 2023. Ann Rheum Dis. 82:198. PubMed
  17. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  18. Klaus T, et al. 2022. JCI Insight. 7: . PubMed
  19. Chen C, et al. 2022. J Neuroinflammation. 19:315. PubMed
  20. An X, et al. 2023. Am J Reprod Immunol. 89:e13676. PubMed
  21. van Lengerich B, et al. 2023. Nat Neurosci. 26:416. PubMed
  22. Taniguchi S, et al. 2023. Nat Commun. 14:143. PubMed
  23. Nettersheim FS, et al. 2023. Front Cardiovasc Med. 9:1076808. PubMed
  24. Quattrocelli M, et al. 2022. J Exp Med. 219:. PubMed
  25. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  26. Chithanathan K, et al. 2022. Front Immunol. 13:996415. PubMed
  27. Reynolds MB, et al. 2023. Sci Adv. 9:eade8701. PubMed
  28. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  29. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  30. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  31. Li Q, et al. 2019. Neuron. 101:207. PubMed
  32. Klemm F, et al. 2020. Cell. 181(7):1643-1660.e17. PubMed
  33. Yan L, et al. 2021. Front Cell Neurosci. 15:750373. PubMed
  34. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  35. Liu X, et al. 2013. Diabetes. 62:4228. PubMed
  36. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  37. Piirsalu M, et al. 2022. Cells. 11:. PubMed
  38. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  39. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  40. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  41. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  42. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
  43. McDowell SAC, et al. 2021. Nat Cancer. 2:545. PubMed
  44. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  45. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  46. Xu D et al. 2018. Cell. 174(6):1477-1491 . PubMed
  47. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  48. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  49. Sokol CL et al. 2018. Immunity. 49(3):449-463 . PubMed
  50. Sabbagh MF et al. 2018. eLife. 7 pii: e36187. PubMed
  51. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  52. Zirngibl F, et al. 2021. J Immunother Cancer. 9:. PubMed
  53. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  54. Singh S, et al. 2021. Cell Host Microbe. 29(3):347-361.e12. PubMed
  55. Bryson BD, et al. 2019. Nat Commun. 10:2329. PubMed
  56. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  57. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  58. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  59. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  60. Weber G, et al. 2014. J Exp Med. 211:1243. PubMed
  61. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  62. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  63. Grzelak A, et al. 2018. Int J Mol Sci. 19:. PubMed
  64. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  65. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  66. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  67. Muraleedharan A, et al. 2021. Glia. 69:697. PubMed
  68. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  69. Bennett M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1738 - 1746. PubMed
  70. O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed
  71. Liakopoulos V, et al. 2018. Sci Rep. 8:13964. PubMed
  72. Kakizaki M, Watanabe R 2017. Neuropathology. 10.1111/neup.12386. PubMed
  73. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  74. Jia P, et al. 2021. Nat Commun. 12:6535. PubMed
  75. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  76. Kodama L, et al. 2020. Nat Neurosci. 1.074305556. PubMed
  77. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  78. Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
  79. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  80. Tummers B, et al. 2020. Immunity. 52(6):994-1006.e8. PubMed
  81. Logan T, et al. 2021. Cell. 184(18):4651-4668.e25. PubMed
  82. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  83. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  84. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
  85. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  86. Zhou T, et al. 2022. Sci Adv. 8:eabj9617. PubMed
  87. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  88. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  89. Motozono C, et al. 2015. J Biol Chem. 290: 18924 - 18933. PubMed
  90. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  91. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  92. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  93. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  94. Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
  95. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  96. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  97. Fujii T, et al. 2021. Bone Res. 9:4. PubMed
  98. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  99. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  100. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  101. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  102. Pribyl M, et al. 2020. Mol Oncol. 2.252083333. PubMed
  103. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  104. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  105. Skucha A, et al. 2018. Nat Commun. 9:1983. PubMed
  106. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  107. Yin Z, et al. 2017. Neurobiol Aging. 10.1016/j.neurobiolaging.2017.03.021. PubMed
  108. Molgora M, et al. 2020. Cell. 182:886. PubMed
  109. Geng X, et al. 2018. Aging (Albany NY). 10:1415. PubMed
  110. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  111. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  112. Sakurai Y, et al. 2021. Pharmaceutics. 13:. PubMed
  113. Heil J, et al. 2021. Nat Commun. 12:6963. PubMed
  114. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  115. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  116. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  117. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  118. Nakayama Y, et al. 2020. Proc Natl Acad Sci U S A. 117:14365. PubMed
  119. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  120. Jolly A, et al. 2022. Cell Rep Methods. 2:100315. PubMed
  121. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  122. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  123. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  124. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  125. Verma M, et al. 2021. J Exp Med. 218:. PubMed
  126. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  127. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  128. Reinert L, et al. 2016. Nat Commun. 7:13348. PubMed
  129. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  130. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  131. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  132. Cho C et al. 2017. Neuron. 95(5):1056-1073 . PubMed
  133. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  134. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  135. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  136. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  137. Kim I et al. 2015. Brain and behavior. 5(12):e00403 . PubMed
  138. Koda S, et al. 2021. Front Immunol. 12:754208. PubMed
RRID
AB_10897942 (BioLegend Cat. No. 101235)
AB_10897942 (BioLegend Cat. No. 101251)
AB_10897942 (BioLegend Cat. No. 101236)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What is the F/P ratio range of our BV421™ format antibody reagents?

It is lot-specific. On average it ranges between 2-4.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account